Glucagon
FDA-approved glucagon products for hypoglycemia rescue and diagnostic uses.
What it's for
Glucagon is a 29–amino-acid pancreatic hormone. Multiple FDA-approved formulations exist (emergency kits, nasal powder, etc.).
What it does for the body
Primary labeled use is raising blood glucose in severe hypoglycemia. Some products have diagnostic GI motility uses per label. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Hepatic glucagon receptors (lock-and-key landing spots on cells) activation mobilizes glycogen to increase circulating glucose. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: Glucagon has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Digestive research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Glucagon — FDA.gov search
- ClinicalTrials.gov search: Glucagon — U.S. clinical trials registry
- Drugs@FDA search: Glucagon — FDA drug database (if approved)
- PubMed search: Glucagon — NCBI PubMed
- PubMed Central search: Glucagon — NCBI PMC
Reference
No ref on file.